Tycoon Group Holdings Limited (HKG:3390)
Hong Kong · Delayed Price · Currency is HKD 0.3200
-0.0050 (-1.56%)
Sep 25, 2025, 4:08 PM HKT
Tycoon Group Holdings Revenue
Tycoon Group Holdings had revenue of 510.08M HKD in the half year ending June 30, 2025, a decrease of -23.44%. This brings the company's revenue in the last twelve months to 951.11M, down -1.68% year-over-year. In the year 2024, Tycoon Group Holdings had annual revenue of 876.04M, down -26.91%.
Revenue (ttm)
951.11M
Revenue Growth
-1.68%
P/S Ratio
0.30
Revenue / Employee
4.06M
Employees
260
Market Cap
286.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 876.04M | -322.61M | -26.91% |
| Dec 31, 2023 | 1.20B | 12.46M | 1.05% |
| Dec 31, 2022 | 1.19B | 297.31M | 33.45% |
| Dec 31, 2021 | 888.87M | 382.88M | 75.67% |
| Dec 31, 2020 | 505.99M | -194.76M | -27.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| JD Health International | 71.34B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |